In This Section

Cancer Molecular Imaging and Theranostics Task Force

The Cancer Molecular Imaging and Theranostics (CMIT) Task Force is committed to accelerating the development, expansion, and application of molecular imaging and theranostic strategies to conquer cancer through:

  • Research
  • Education
  • Communication and scholarly discussion
  • Cross-disciplinary collaboration

CMIT fosters research in novel molecular targeting; furthers understanding of biological mechanisms that drive clinical response; and provides a forum for scholarly discussion and dissemination of research findings on molecular imaging, diagnostics, biomarkers, and radiopharmaceutical therapy among laboratory, translational, and clinical researchers.

Kayvan R. Keshari, PhD
Co-Chair

Kayvan R. Keshari, PhD

(2023-2025)

Member and Professor
Fred Lebow Chair
Memorial Sloan Kettering Cancer Center
New York, New York

David R. Piwnica-Worms, MD, PhD
Co-Chair

David R. Piwnica-Worms, MD, PhD

(2023-2025)

Chair and Professor
Cancer Systems Imaging
MD Anderson Cancer Center
Houston, Texas

Julie L. Sutcliffe, PhD
Co-Chair

Julie L. Sutcliffe, PhD

(2023-2025)

Professor, Hematology and Oncology
University of California, Davis
Davis, California

Eric Aboagye, PhD

Eric Aboagye, PhD

(2023-2025)

Professor, Faculty of Medicine,
Department of Surgery and Cancer
Imperial College London
London, United Kingdom

Zaver M. Bhujwalla, PhD, MSc

Zaver M. Bhujwalla, PhD, MSc

(2023-2025)

Director, Division of Cancer Imaging Research,
Department of Radiology
Professor of Radiology and Radiological Science
Johns Hopkins University
Baltimore, Maryland

E.G. Elisabeth de Vries, MD, PhD

E.G. Elisabeth de Vries, MD, PhD

(2023-2025)

Professor of Medical Oncology
University Medical Centre Groningen
Groningen, the Netherlands

 

Ralph DeBerardinis, MD, PhD

Ralph DeBerardinis, MD, PhD

(2023-2025)

Professor, Children’s Medical Center Research Institute
UT Southwestern Pediatrics Institute of Cancer Research
Dallas, Texas

James R. Heath, PhD

James R. Heath, PhD

(2023-2025)

President and Professor
Institute for Systems Biology
Seattle, Washington

Oluwatayo Ikotun, PhD

Oluwatayo Ikotun, PhD

(2023-2025)

Assistant Professor
Department of Molecular and Medical Pharmacology
University of California, Los Angeles
Los Angeles, California

David C. Lyden, MD, PhD

David C. Lyden, MD, PhD

(2023-2025)

Professor of Pediatrics
Weill Cornell Medical College
New York, New York

David A. Mankoff, MD, PhD

David A. Mankoff, MD, PhD

(2023-2025)

Vice Chair for Research, Radiology
Matthew J. Wilson Professor of Research Radiology
University of Pennsylvania
Philadelphia, Pennsylvania

Florencia McAllister, MD

Florencia McAllister, MD

(2023-2025)

Associate Professor
Department of Clinical Cancer Prevention and Gastrointestinal Medical Oncology
MD Anderson Cancer Center
Houston, Texas

Jeffrey C. Rathmell, PhD

Jeffrey C. Rathmell, PhD

(2023-2025)

MPI Associate Director
Cornelius Vanderbilt Professor of Immunobiology
Director, Vanderbilt Center for Immunobiology
Nashville, Tennessee

David A. Tuveson, MD, PhD, FAACR

David A. Tuveson, MD, PhD, FAACR

(2023-2025)

Director and Roy J. Zuckerberg Professor of Cancer Research
Cold Spring Harbor Laboratory
Cold Spring Harbor, New York

Jeevan Virk

Jeevan Virk

(2023-2025)

Head of Radioligand Therapy
Novartis
Geneva, Switzerland